ImmunityBio ClinicalTrials.gov Study Record Detail For Co.'s 'A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies,' Shows Not Yet Recruiting